跳至主要内容
临床试验/EUCTR2006-005471-18-GB
EUCTR2006-005471-18-GB进行中(未招募)1 期

Topical Capsaicin 0.025% as a treatment for Achilles tendinopathy. A prospective, double blinded, randomised controlled trial with multiple outcome measures.

Sheffield Teaching Hospitals NHS Foundation Trust0 个研究点目标入组 0 人开始时间: 2007年8月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Aged 18 - 65 years of age to ensure skeletal maturity, and try to exclude
  • degenerative changes seen in the elderly.
  • 2. Patients able to give informed consent.
  • 3. Confirmed diagnosis of Achilles tendinopathy (tendinosis) of greater than 3
  • months duration - implying treatment is required as the condition is unlikely to
  • resolve spontaneously.
  • 4. Do not have any contraindications to the topical cream (e.g. allergies).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Systemic inflammatory condition (e.g. rheumatoid arthritis) as a cause of the
  • condition – i.e. requires additional treatment.
  • 2. Pre-existing concurrent pathology or deformity that may be the cause of pain or
  • functional deficits.
  • 3. Previous history of surgery to the ankle / lower limb, specifically the Achilles
  • 4. Any women who are or could possibly be pregnant.

研究者

相似试验